Neuronetics Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 2.32
Dividend & YieldN/A$ (N/A)
Beta 1.99
Market capitalization 163.33M
Operating cash flow -32.16M
ESG Scores unknown

Company description

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Sector: Healthcare - Industry: Diagnostics & Research

Financial Ratios
Quick Ratio6.93
Working Capital-0.31
Return On Equity-0.37
Debt To Equity0.41
Fixed Asset Ratio-0.18
Fixed Interest Cover-6.73

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 557k 437k -1.66M 491k
Total Cashflows From Investing Activities -1.01M -813k -730k -9.84M
Net Borrowings 2.5M 2.5M 2.5M
Total Cash From Financing Activities 97.04M 2.42M 2.37M 83.01M
Change To Operating Activities -352k -6.09M -5.08M -630k
Issuance Of Stock 100.5M 2.42M 690k 83.41M
Net Income -24.1M -29.04M -27.45M -31.19M
Change In Cash 75.44M -28.88M -26.75M 45.18M
Effect Of Exchange Rate
Total Cash From Operating Activities -20.59M -30.48M -28.39M -27.98M
Depreciation 882k 1.06M 941k 1.06M
Change To Account Receivables -1.35M -950k -597k -3.05M
Other Cashflows From Financing Activities -3.46M -821k -821k -401k
Change To Netincome 4.21M 4.41M 6.4M 8.79M
Capital Expenditures -1.01M -813k -730k -2.35M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 8.23M 13.75M 9.2M 7.92M
Income Before Tax -24.1M -29.04M -27.45M -31.19M
Net Income -24.1M -29.04M -27.45M -31.19M
Selling General Administrative 51.93M 60.45M 49M 62.8M
Gross Profit 40.33M 47.27M 37.69M 43.66M
Ebit -19.83M -26.93M -20.51M -27.06M
Operating Income -19.83M -26.93M -20.51M -27.06M
Interest Expense -3.69M -3.69M -4.52M -4.02M
Income Tax Expense
Total Revenue 52.78M 62.66M 49.24M 55.31M
Cost Of Revenue 12.45M 15.39M 11.55M 11.65M
Total Other Income ExpenseNet -4.26M -2.11M -6.94M -4.13M
Net Income From Continuing Ops -24.1M -29.04M -27.45M -31.19M
Net Income Applicable To Common Shares -24.1M -29.04M -27.45M -31.19M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 45.98M 52.32M 53.16M 56.05M
Total Stockholder Equity 71.04M 47.85M 25.49M 85.17M
Other Current Liabilities 2.88M 2.87M 2.56M 2.81M
Total Assets 117.02M 100.17M 78.66M 141.22M
Common Stock 177k 186k 191k 264k
Other Current Assets 689k 1.1M 1.56M
Retained Earnings -221.04M -250.09M -277.54M -308.73M
Treasury Stock
Cash 104.58M 75.71M 48.96M 94.14M
Total Current Liabilities 13.56M 27.69M 13.68M 15.7M
Other Stockholder Equity
Property, Plant, and Equipment 1.38M 4.9M 4.15M 5.1M
Total Current Assets 114.47M 88.45M 65.01M 115.33M
Net Tangible Assets 70.04M 46.65M 24.29M 85.17M
Net Receivables 5.62M 7.45M 9.05M 9.98M
Accounts Payable 3.76M 4.62M 3.75M 4.3M


Insider Transactions

Here are the insider transactions of stock shares related to Neuronetics Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
SULLIVAN KEITH JConversion of Exercise of derivative security at price 1.98 per share.D2022-10-20Chief Executive Officer100k
FURLONG STEPHENSale at price 2.97 per share.D2022-10-11Chief Financial Officer1.63k
MACAN WILLIAM ANDREWSale at price 2.82 - 2.93 per share.D2022-10-10General Counsel1.62k
FURLONG STEPHENSale at price 3.54 per share.D2022-07-25Chief Financial Officer13.32k
SULLIVAN KEITH JSale at price 3.72 per share.D2022-07-18Chief Executive Officer63.47k
MACAN WILLIAM ANDREWSale at price 3.60 per share.D2022-07-08General Counsel2.75k
CANNELL CAPITAL, L.L.C.Purchase at price 3.09 - 3.57 per share.I2022-06-17Beneficial Owner of more than 10% of a Class of Security5.07k
CANNELL CAPITAL, L.L.C.Purchase at price 3.46 - 3.57 per share.I2022-06-14Beneficial Owner of more than 10% of a Class of Security7.04k
CANNELL CAPITAL, L.L.C.Purchase at price 2.69 per share.I2022-06-03Beneficial Owner of more than 10% of a Class of Security10k
CANNELL CAPITAL, L.L.C.Purchase at price 2.44 - 2.75 per share.I2022-05-31Beneficial Owner of more than 10% of a Class of Security9.55k
BAKEWELL JOHN KStock Award(Grant) at price 0.00 per share.D2022-05-26Director38.91k
MUIR GLENN PStock Award(Grant) at price 0.00 per share.D2022-05-26Director38.91k
JAEGER WILFRED EStock Award(Grant) at price 0.00 per share.D2022-05-26Director38.91k
CASCELLA ROBERT AStock Award(Grant) at price 0.00 per share.D2022-05-26Director48.64k
CONLEY SHERYL LStock Award(Grant) at price 0.00 per share.D2022-05-26Director38.91k
SHOOK BRUCE JOSEPHStock Award(Grant) at price 0.00 per share.D2022-05-26Director38.91k
ROSENGARTEN MEGANStock Award(Grant) at price 0.00 per share.D2022-05-26Director38.91k
CANNELL CAPITAL, L.L.C.Purchase at price 2.34 - 2.46 per share.I2022-05-25Beneficial Owner of more than 10% of a Class of Security36.12k
CANNELL CAPITAL, L.L.C.Purchase at price 2.33 - 2.41 per share.I2022-05-20Beneficial Owner of more than 10% of a Class of Security63.91k
CANNELL CAPITAL, L.L.C.Purchase at price 2.13 - 2.19 per share.I2022-05-11Beneficial Owner of more than 10% of a Class of Security121.65k
CANNELL CAPITAL, L.L.C.Purchase at price 2.31 - 2.44 per share.I2022-05-09Beneficial Owner of more than 10% of a Class of Security25.15k
CANNELL CAPITAL, L.L.C.Purchase at price 2.47 - 2.53 per share.I2022-05-04Beneficial Owner of more than 10% of a Class of Security40.43k
CANNELL CAPITAL, L.L.C.Purchase at price 2.70 - 2.85 per share.I2022-04-26Beneficial Owner of more than 10% of a Class of Security10.81k
CANNELL CAPITAL, L.L.C.Purchase at price 2.89 per share.I2022-04-19Beneficial Owner of more than 10% of a Class of Security206
CANNELL CAPITAL, L.L.C.Purchase at price 2.88 - 2.95 per share.I2022-04-13Beneficial Owner of more than 10% of a Class of Security134.32k
CANNELL CAPITAL, L.L.C.Purchase at price 3.16 per share.I2022-04-06Beneficial Owner of more than 10% of a Class of Security2.83k
CANNELL CAPITAL, L.L.C.Purchase at price 2.99 - 3.00 per share.I2022-04-01Beneficial Owner of more than 10% of a Class of Security265.31k
CANNELL CAPITAL, L.L.C.Purchase at price 2.94 - 2.99 per share.I2022-03-28Beneficial Owner of more than 10% of a Class of Security60.85k
FURLONG STEPHENSale at price 3.00 per share.D2022-03-09Chief Financial Officer10.03k
MACAN WILLIAM ANDREWSale at price 2.85 - 3.14 per share.D2022-03-08General Counsel11.63k
SULLIVAN KEITH JStock Award(Grant) at price 0.00 per share.D2022-02-09Chief Executive Officer283.91k
MACAN WILLIAM ANDREWStock Award(Grant) at price 0.00 per share.D2022-02-09General Counsel166.56k
FURLONG STEPHENSale at price 3.12 - 3.14 per share.D2022-02-09Chief Financial Officer5.35k
FURLONG STEPHENStock Award(Grant) at price 0.00 per share.D2022-02-09Chief Financial Officer176.66k
MACAN WILLIAM ANDREWSale at price 3.26 - 3.27 per share.D2022-02-08General Counsel4.73k
MACAN WILLIAM ANDREWSale at price 3.52 per share.D2022-01-24General Counsel11.56k
FURLONG STEPHENSale at price 3.40 - 3.62 per share.D2022-01-24Chief Financial Officer17.46k
CASCELLA ROBERT APurchase at price 4.10 per share.D2021-11-22Director15k
SHOOK BRUCE JOSEPHSale at price 5.30 per share.D2021-11-12Director7.8k
SHOOK BRUCE JOSEPHConversion of Exercise of derivative security at price 4.06 per share.D2021-11-12Director7.8k
MACAN WILLIAM ANDREWStock Award(Grant) at price 0.00 per share.D2021-10-04General Counsel10k
FURLONG STEPHENStock Award(Grant) at price 0.00 per share.D2021-10-04Chief Financial Officer10k
CASCELLA ROBERT APurchase at price 6.72 per share.D2021-08-30Director15k
ROSENGARTEN MEGANStock Award(Grant) at price 0.00 per share.D2021-08-04Director10.62k
FURLONG STEPHENSale at price 13.08 per share.D2021-07-28Chief Financial Officer6.56k
SULLIVAN KEITH JSale at price 13.46 - 13.64 per share.D2021-07-16Chief Executive Officer50.99k
MACAN WILLIAM ANDREWSale at price 14.61 per share.D2021-07-08General Counsel2.59k
FURLONG STEPHENSale at price 15.00 per share.D2021-06-04Chief Financial Officer2.47k
CONLEY SHERYL LSale at price 14.03 per share.D2021-06-01Director6.2k
CONLEY SHERYL LSale at price 13.78 per share.D2021-05-28Director6.8k
BAKEWELL JOHN KStock Award(Grant) at price 0.00 per share.D2021-05-27Director7.14k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Neuronetics Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Neuronetics Inc

Here is the result of two systematic investment strategies applied to Neuronetics Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Neuronetics Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Neuronetics Inc:

Neuronetics Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 11.56% on the backtest period.

Performance at glance

Performance

11.56 %

Latent gain

203.54 $

Invested capital

1760.89 $

Annualized return

3.4 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Neuronetics Inc

This is the result of two momentum investment strategies applied to Neuronetics Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Neuronetics Inc

The following chart shows all the entries opened by the momentum investment system on Neuronetics Inc:

Neuronetics Inc momentum entries
  • The first momentum investment strategy would give 10.35% of return on Neuronetics Inc. That represents 337.59$ of latent gain with 3262.77$ of employed capital.
  • The second momentum investment strategy would give 49.83% of return on Neuronetics Inc. That represents 869.68$ of latent gain with 1745.18$ of employed capital.
Performance at glance (1Q Momentum)

Performance

10.35 %

Latent gain

337.59 $

Invested capital

3262.77 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

49.83 %

Latent gain

869.68 $

Invested capital

1745.18 $

Annualized return

17.07 %

Momentum equity curve on Neuronetics Inc

The following chart shows the equity curve of the two momentum strategies applied to Neuronetics Inc:

Neuronetics Inc momentum equity

Note: the dividends potentially given by Neuronetics Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Neuronetics Inc

The following chart shows the employed capital evolution of the two momentum strategies on Neuronetics Inc since the beginning:

Neuronetics Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Neuronetics Inc

Buy the dip entry openings on Neuronetics Inc

Neuronetics Inc

The performance achieved by the robo-advisor on Neuronetics Inc is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Neuronetics Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Neuronetics Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Neuronetics Inc

The following chart shows the result of the investment strategy applied to Neuronetics Inc:

Neuronetics Inc

Note: the dividends potentially given by Neuronetics Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Neuronetics Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Neuronetics Inc:

Neuronetics Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Neuronetics Inc

In this section, I will compare the three previous investment strategies applied to Neuronetics Inc.

Equity curve comparison on Neuronetics Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Neuronetics Inc investment strategy comparison

Employed capital comparison on Neuronetics Inc

Neuronetics Inc investment comparison

Performance comparison on Neuronetics Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 11.56% 203.54$ 1760.89$ 3.4%
Momentum 1 quarter 10.35% 337.59$ 3262.77$ 3.28%
Momentum 2 quarters 49.83% 869.68$ 1745.18$ 17.07%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

3.4 %

Momentum 1Q

17.07 %

Momentum 2Q

17.07 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Neuronetics Inc:

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months


Note: The algorithm computes the probability of correlation between Neuronetics Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Neuronetics Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Neuronetics Inc
Country United States
City Malvern
Address 3222 Phoenixville Pike
Phone 610 640 4202
Website www.neurostar.com
FullTime employees 198
Industry Diagnostics & Research
Sector Healthcare
Exchange XNAS
Ticker STIM
Market www.nasdaq.com

Neuronetics Inc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown